(I), values of radicals are given in invention formula. Also described is pharmaceutical composition based on formula (I) compound.;EFFECT: compounds can be used for inhibition of prostaglandin E2 binding with receptor EP3.;30 cl, 371 ex, 4 tbl"/>
公开/公告号RU2403240C2
专利类型
公开/公告日2010-11-10
原文格式PDF
申请/专利权人 DEKOD DZHENETIKS EKHF;
申请/专利号RU20070115410
发明设计人 CHZHOU NIAN (US);SINGKH DZHASBIR (US);GARNI MARK (US);KHEJTGAN DZHORDZHETA (US);JUJ PEHN (US);ZEMBAUEHR DEHVID (US);
申请日2005-06-27
分类号C07D209/12;C07D209/30;C07D209/34;C07D401/12;C07D409/12;C07D409/14;C07D413/12;C07D487/04;C07D513/04;A61K31/404;A61K31/416;A61K31/4162;A61P9/10;
国家 RU
入库时间 2022-08-21 18:29:26